cerebral infarction ischemic stroke
Conditions
Interventions
In 1981, CPAP was introduced for the treatment of patients with OSA. Since
then, CPAP is considered the gold standard treatment in patients with moderate
to severe OSA. CPAP acts as a pneumatic spli
Sponsors
OLVG
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: * 18 years and older * First-ever AIS (onset
Exclusion criteria
Exclusion criteria: * Medical history of IS * Medical history of OSA * Hemorrhagic stroke * TIA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is feasibility defined as CPAP compliance during the study period. Compliance is expressed as the average use of CPAP per night measured by a memory card integrated in the CPAP device. Good compliance will be defined as an average usage of more than 4 hoursper night. | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: - Inclusion rate - Adverse events (AE): CPAP related AEs - Percentage of withdrawal from CPAP treatment - Self-evaluation of CPAP by patients and their caregivers - Functional status: The National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) - Cognitive status: Montreal Cognitive Assessment (MoCA) and Trail Making Test (TMT) - OSA prevalence measured by polysomnography (PSG) - Epworth Sleepiness Scale (ESS) | — |
Countries
Netherlands
Outcome results
None listed